Our marker detection capabilities are designed for granular identification of RBC surface antigens and associated genetic predispositions:
Antibody Screening and Identification: A critical component for transfusion safety and prenatal care, this service meticulously detects the presence of irregular antibodies in patient or donor plasma that could potentially react with transfused RBCs.
RBC Genotyping: Going beyond traditional serological phenotyping, Creative Biolabs utilizes advanced genetic testing to ascertain the precise allelic variations encoding specific blood group antigens. This is particularly invaluable in scenarios where serological results are ambiguous or unreliable, such as in recently transfused patients where transfused cells can mask the recipient's true phenotype, in individuals with a positive Direct Antiglobulin Test (DAT), or when certain medications interfere with antibody binding.
Flow Cytometry for Comprehensive Marker Analysis: Utilizing state-of-the-art flow cytometry, Creative Biolabs can rapidly analyze multiple physical and fluorescent characteristics of individual RBCs. This enables the quantification of various surface markers, assessment of intracellular components, and identification of subtle shifts in RBC populations, providing deeper insights into cellular states in both healthy and diseased conditions.
Fig.1 The relevant cells or components that interact with red blood cells in vessel.1